Filing #7311866

Available Statements

Solasia Pharma K.K. - filed on August 14, 2024

Management Analysis Of Financial Position, Operating Results And Cash Flows

Taxonomy: jpcrp-2022

Statement Of Financial Position

Taxonomy: jpigp-2021

Comprehensive Income Attributable To

Taxonomy: jpigp-2023

Equity Attributable To Owners Of Parent

Taxonomy: jpigp-2021

Consolidated Statement Of Cash Flows

Taxonomy: jpigp-2021

Authorized Shares

Taxonomy: jpcrp-2020

Business Results Of Group

Taxonomy: jpcrp-2013

Business Risks

Taxonomy: jpcrp-2023

Components Of Inventories

Taxonomy: jpigp-2020

Contract Of Tender Offer

Taxonomy: jpcrp-2020

Cover Page

Taxonomy: jpcrp-2021

Dividend Income

Taxonomy: jpigp-2018

Earnings (Loss) Per Share

Taxonomy: jpigp-2019

Financial Information

Taxonomy: jpcrp-2013

Financial Statements, Etc.

Taxonomy: jpcrp-2023

Issued Shares

Taxonomy: jpcrp-2019

Major Shareholders

Taxonomy: jpcrp-2020

Notes

Taxonomy: jpcrp-2023

Notes - Asset Retirement Obligations

Taxonomy: jpcrp-2022

Notes - Balance Sheet

Taxonomy: jpcrp-2022

Notes - Discontinued Operations

Taxonomy: jpigp-2021

Notes - Per Share Information

Taxonomy: jpcrp-2021

Notes - Property, Plant And Equipment

Taxonomy: jpigp-2018

Notes - Revenue Recognition

Taxonomy: jpcrp-2020

Notes - Segment Information

Taxonomy: jpigp-2019

Notes - Selling, General And Administrative Expenses

Taxonomy: jpigp-2022

Notes - Valuation Difference On Available-For-Sale Securities

Taxonomy: jpcrp-2020

Secondary Distribution Of Depositary Receipts And Beneficiary Certificates Of Securities In Trust

Taxonomy: jpcrp-2022

Segment Information

Taxonomy: jpigp-2019

Sequential Numbers

Taxonomy: jpcrp-2022

Shares Less Than One Unit

Taxonomy: jpcrp-2019

Terms Of Public Offering

Taxonomy: jpcrp-2021

Talk to a Data Expert

Have a question? We'll get back to you promptly.